The University of Chicago Header Logo

Connection

Peter Sand to Urinary Incontinence

Back to Details
This is a "connection" page, showing publications Peter Sand has written about Urinary Incontinence.
Peter Sand
Connection Strength
6.733
Urinary Incontinence
  1. Can patients independently identify their urinary incontinence symptoms? Int Urogynecol J. 2021 Feb; 32(2):381-385.
    View in: PubMed
    Score: 0.635
  2. Counseling in urogynecology: A difficult task, or simply good surgeon-patient communication? Int Urogynecol J. 2018 07; 29(7):943-948.
    View in: PubMed
    Score: 0.548
  3. Evaluation and treatment of female urinary incontinence. Minerva Urol Nefrol. 2007 Dec; 59(4):431-50.
    View in: PubMed
    Score: 0.265
  4. Evaluation and treatment of female urinary incontinence. Panminerva Med. 2007 Sep; 49(3):159-75.
    View in: PubMed
    Score: 0.260
  5. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int. 2007 Apr; 99(4):836-44.
    View in: PubMed
    Score: 0.248
  6. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol. 2006 Dec; 195(6):1730-5.
    View in: PubMed
    Score: 0.247
  7. Disruptive effects of overactive bladder and urge urinary incontinence in younger women. Am J Med. 2006 Mar; 119(3 Suppl 1):16-23.
    View in: PubMed
    Score: 0.234
  8. Diagnosis and treatment of overactive bladder. Minerva Ginecol. 2005 Oct; 57(5):501-20.
    View in: PubMed
    Score: 0.228
  9. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol. 2005 Jun; 192(6):1849-54; discussion 1854-5.
    View in: PubMed
    Score: 0.223
  10. Urinary incontinence after multiple gestation and delivery: impact on quality of life. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct; 16(5):334-6.
    View in: PubMed
    Score: 0.218
  11. Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review. Expert Opin Pharmacother. 2004 Nov; 5(11):2351-9.
    View in: PubMed
    Score: 0.214
  12. Elevating our therapeutic expectations in overactive bladder. J Am Acad Nurse Pract. 2004 Oct; 16(10 Suppl):8-11.
    View in: PubMed
    Score: 0.213
  13. Urinary incontinence among mothers of multiples: the protective effect of cesarean delivery. Am J Obstet Gynecol. 2003 Jun; 188(6):1447-50; discussion 1450-3.
    View in: PubMed
    Score: 0.194
  14. Extracorporeal electromagnetic stimulation for urinary incontinence and bladder disease. Adv Exp Med Biol. 2003; 539(Pt A):453-65.
    View in: PubMed
    Score: 0.188
  15. Electromagnetic pelvic floor stimulation for urinary incontinence and bladder disease. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(6):401-4.
    View in: PubMed
    Score: 0.164
  16. Electromagnetic pelvic floor stimulation: applications for the gynecologist. Obstet Gynecol Surv. 2000 Nov; 55(11):715-20.
    View in: PubMed
    Score: 0.162
  17. Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. Urology. 1999 Sep; 54(3):420-3.
    View in: PubMed
    Score: 0.149
  18. Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence. Neurourol Urodyn. 2019 02; 38(2):825-837.
    View in: PubMed
    Score: 0.142
  19. Treatment of detrusor instability with oxybutynin rectal suppositories. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(2):100-2.
    View in: PubMed
    Score: 0.133
  20. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223.
    View in: PubMed
    Score: 0.124
  21. The empty supine stress test as a predictor of intrinsic urethral sphincter dysfunction. Obstet Gynecol. 1996 Jul; 88(1):128-32.
    View in: PubMed
    Score: 0.120
  22. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2015 Jan; 34(1):37-43.
    View in: PubMed
    Score: 0.099
  23. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93.
    View in: PubMed
    Score: 0.094
  24. Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB. Int Urogynecol J. 2012 Aug; 23(8):1017-25.
    View in: PubMed
    Score: 0.088
  25. Simple standing incremental cystometry as a screening method for detrusor instability. Obstet Gynecol. 1991 Mar; 77(3):453-7.
    View in: PubMed
    Score: 0.083
  26. Nonsurgical treatment of detrusor overactivity in postmenopausal women. J Reprod Med. 1990 Aug; 35(8):758-64.
    View in: PubMed
    Score: 0.080
  27. Cystometry, urethrocystometry, and videocystourethrography. Clin Obstet Gynecol. 1990 Jun; 33(2):315-24.
    View in: PubMed
    Score: 0.079
  28. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary incontinence and for fecal incontinence. Part 1: Innovations in urodynamic techniques and urodynamic testing for signs and symptoms of urinary incontinence in female patients. Neurourol Urodyn. 2010; 29(1):140-5.
    View in: PubMed
    Score: 0.076
  29. Executive Summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 3: Anorectal physiology studies. Neurourol Urodyn. 2010; 29(1):153-8.
    View in: PubMed
    Score: 0.076
  30. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 2: Urodynamic testing in male patients with symptoms of urinary incontinence, in patients with relevant neurological abnormalities, and in children and in frail elderly with symptoms of urinary incontinence. Neurourol Urodyn. 2010; 29(1):146-52.
    View in: PubMed
    Score: 0.076
  31. Editorial comment on "An International Urogynecological Association (IUGA)/International continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction". Neurourol Urodyn. 2010; 29(1):3.
    View in: PubMed
    Score: 0.076
  32. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009; 28(4):287.
    View in: PubMed
    Score: 0.071
  33. Subjective measures of efficacy and quality of life in overactive bladder syndrome. Curr Urol Rep. 2008 Sep; 9(5):368-72.
    View in: PubMed
    Score: 0.070
  34. Incontinence history as a predictor of detrusor stability. Obstet Gynecol. 1988 Feb; 71(2):257-60.
    View in: PubMed
    Score: 0.067
  35. Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
    View in: PubMed
    Score: 0.063
  36. The low pressure urethra as a factor in failed retropubic urethropexy. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):399-402.
    View in: PubMed
    Score: 0.063
  37. Uninhibited urethral relaxation: an unusual cause of incontinence. Obstet Gynecol. 1986 Nov; 68(5):645-8.
    View in: PubMed
    Score: 0.061
  38. Perceptions and behaviours of women with bladder control problems. Fam Pract. 2006 Oct; 23(5):568-77.
    View in: PubMed
    Score: 0.060
  39. Management of incontinence for family practice physicians. Am J Med. 2006 Mar; 119(3 Suppl 1):37-40.
    View in: PubMed
    Score: 0.059
  40. The tensile strength of Cooper's ligament suturing: comparison of abdominal and transvaginal techniques. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec; 15(6):425-7; discussion 428.
    View in: PubMed
    Score: 0.052
  41. Eosinophilic cystitis after bladder instillation with dimethyl sulfoxide. Urology. 2004 Jun; 63(6):1182-3.
    View in: PubMed
    Score: 0.052
  42. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc. 2003 Jun; 78(6):687-95.
    View in: PubMed
    Score: 0.048
  43. The use of intraoperative cystoscopy in major vaginal and urogynecologic surgeries. Am J Obstet Gynecol. 2002 Dec; 187(6):1466-71; discussion 1471-2.
    View in: PubMed
    Score: 0.047
  44. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
    View in: PubMed
    Score: 0.044
  45. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001 Dec; 185(6):1307-12; discussion 1312-3.
    View in: PubMed
    Score: 0.044
  46. Early-stage ovarian carcinoma presenting with irritative voiding symptoms and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(5):342-4.
    View in: PubMed
    Score: 0.041
  47. Anterior Colporrhaphy With and Without Dermal Allograft: A Randomized Control Trial With Long-Term Follow-Up. Female Pelvic Med Reconstr Surg. 2019 May-Jun; 25(3):206-212.
    View in: PubMed
    Score: 0.036
  48. Incisional hernia after suprapubic catheterization. Obstet Gynecol. 1997 May; 89(5 Pt 2):844-6.
    View in: PubMed
    Score: 0.032
  49. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29(1):4-20.
    View in: PubMed
    Score: 0.019
  50. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010 Jan; 21(1):5-26.
    View in: PubMed
    Score: 0.019
  51. The effect of retropubic urethropexy on detrusor stability. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):818-22.
    View in: PubMed
    Score: 0.017
  52. Supine urethroscopic and standing cystometry as screening methods for the detection of detrusor instability. Obstet Gynecol. 1987 Jul; 70(1):57-60.
    View in: PubMed
    Score: 0.016
  53. Voiding dysfunction in the adolescent. Obstet Gynecol Surv. 1986 Jun; 41(6):342-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.